Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe

Updated ADHD guideline addresses evaluation, diagnosis, treatment from ages 4-18

Mark L. Wolraich, M.D., FAAP and Joseph F. Hagan Jr., M.D., FAAP
September 30, 2019
  • AAP Policy

The release of revised AAP guidelines for the care of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) offers clinicians updates and opportunities as they strive to provide excellent care.

Clinical Practice Guideline for the Diagnosis, Evaluation and Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents —as well as a process of care algorithm and a paper on barriers to care —are available at https://doi.org/10.1542/peds.2019-2528 and will be published in the October issue of Pediatrics.

The complex care of patients with ADHD occurs best in the patient-centered medical home. Updated from 2011, the guidelines are relevant for primary care pediatricians, pediatric nurse practitioners and physician assistants, and those in family medicine.

Diagnosis

The guidelines on establishing the diagnosis are based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). The DSM-5 criteria are similar to the 2011 guidelines with two exceptions. Fewer problem behaviors are required for those 17 years or older, and there must be evidence that symptoms began before age 12 years instead of before age 7.

The guidelines also emphasize ruling out other causes of ADHD-like symptoms and identifying comorbid conditions.

Therapies, tools for treatment

Recommended treatments also remain essentially unchanged. The stimulant medications methylphenidate and amphetamines in their various forms generally are the initial treatments. The number of extended-release forms of stimulant medications has increased since the last guideline was published.

Atomoxetine and the extended-release alpha-2 agonists guanfacine and clonidine remain the secondary alternative medications. The extended-release alpha-2 agonists also are approved by the Food and Drug Administration as adjuvant treatments.

Behavior therapy is recommended as the first-line treatment for preschoolers. However, the guideline authors determined that descriptions of behavior therapy for children were not specific enough. Studies that were reviewed predominantly included recommendations for parents and other caregivers. Therefore, the guidelines describe behavior management for preschoolers with ADHD as parent training in behavior management. Of note, a few studies described some value to similar parent and teacher training in behavior management for high school students with ADHD.

Supplemental information

An updated process of care algorithm includes additional assessment tools with rating scales for anxiety, depression, substance abuse and trauma.

The guidelines and algorithm continue to emphasize the importance of considering ADHD as a chronic illness for which there are effective symptomatic treatments but no cure. Some individuals, however, attain the ability to compensate adequately as they mature. As ADHD is a chronic illness, ongoing care based on the principles employed in providing medical home services are useful for care.

A companion paper discusses the challenges clinicians experience in seeking to implement the guidelines, including inadequate payment for services, less-than-adequate pediatric training in mental health, limited consultative services, and barriers to communication with schools and consultative services. The paper also provides suggestions for how clinicians, families and organizations can help address these barriers.

A historical commentary on the diagnosis and treatment of ADHD provides perspective to better understand the basis for the clinical guidelines and their subsequent revisions.

It is available at https://doi.org/10.1542/peds.2019-1682 and also will be published in the October issue of Pediatrics.

Evolution of the guidelines

Pediatricians have been involved in clinical services and research for children with ADHD going back at least 50 years. To improve the quality of clinical services for patients with ADHD, the AAP published clinical guidelines for diagnosis in 2000 and for treatment in 2001. These guidelines established the use of the DSM criteria for diagnosis, recommended behavioral rating scales to help establish the diagnosis, and outlined standards for follow-up and monitoring.

The clinical guidelines were revised in 2011 with essentially the same recommendations. However, the applicable age for diagnosis and treatment, which had been from 6-12 years of age, was broadened to include preschoolers (4- to 6-year-olds) and adolescents up to age 18 years. An algorithm on how to implement the revised guidelines also was published.

The changes led to more quality improvement and Maintenance of Certification (MOC) projects, including a revised ADHD toolkit, Education in Quality Improvement for Pediatric Practice module and American Board of Pediatrics MOC modules on diagnosis and treatment.

The AAP has been a leader in improving the care of children with ADHD. It has played a leading role in defining appropriate diagnostic and treatment standards and developing tools clinicians can use meet the standards. The guidelines have set a standard of care and a format for helping clinicians meet that standard.

Drs. Wolraich and Hagan are lead authors of the guideline. Dr. Wolraich is chair and Dr. Hagan vice chair of the Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.

Resources
  • Caring for Children with ADHD: A Practical Resource Toolkit for Clinicians, Third Edition (available early October)
  • Session at the 2019 National Conference: “How Will the New ADHD Guidelines Impact Your Practice?” from 7:30-8:15 a.m. on Oct. 28 (F4012) and 7:30-8:15 a.m. on Oct. 29 (F5009)
  • "ADHD: What Every Parent Needs to Know, Third Edition"
Copyright © 2019 American Academy of Pediatrics

Advertising Disclaimer »

Download PDF
Email News Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Updated ADHD guideline addresses evaluation, diagnosis, treatment from ages 4-18
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Updated ADHD guideline addresses evaluation, diagnosis, treatment from ages 4-18
Mark L. Wolraich, M.D., FAAP and Joseph F. Hagan Jr., M.D., FAAP
September 30, 2019
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Digital Edition Current Issue
  • Latest Daily News
  • Archives
  • Collections
  • Columns
  • Advertising
  • Subscribe to AAP News Magazine
  • Terms of Use
  • Privacy Statement
  • FAQ
  • Contact Us
  • 2021 AAP Journals Catalog
  • Pediatrics
  • Pediatrics in Review
  • Hospital Pediatrics
  • NeoReviews
  • AAP Grand Rounds
  • AAP Career Center
  • shopAAP
  • AAP.org
  • AAP News
  • Visit AAP News on Facebook
  • Follow AAP News on Twitter
American Academy of Pediatrics

© 2021 American Academy of Pediatrics